United States · FDA National Drug Code directory

Cyclobenzaprine Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 64980-657_0512aebe-5f3a-4d41-9a41-7c37e001af75
Product NDC: 64980-657
Form: TABLET
Composition / generic term: Cyclobenzaprine Hydrochloride
Labeler: Rising Pharma Holdings, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20250219
Source listing expiry: 20261231

Source-listed ingredients

CYCLOBENZAPRINE HYDROCHLORIDE — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 TABLET in 1 BOTTLE (64980-657-01) · 64980-657-01
1000 TABLET in 1 BOTTLE (64980-657-10) · 64980-657-10
500 TABLET in 1 BOTTLE (64980-657-50) · 64980-657-50

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →